gefitinib has been researched along with Pituitary Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ben-Shlomo, A; Cooper, O | 1 |
| Chen, H; Deng, J; Guo, G; Liu, Y; Peng, X; Tong, A; Wang, Y; Xu, J; You, C; Zhou, L | 1 |
| Donangelo, I; Gutman, S; Melmed, S; Ren, SG; Siegel, E; Vlotides, G | 1 |
1 review(s) available for gefitinib and Pituitary Neoplasms
| Article | Year |
|---|---|
Role of tyrosine kinase inhibitors in the treatment of pituitary tumours: from bench to bedside.
Topics: Animals; Cell Line, Tumor; ErbB Receptors; Gefitinib; Humans; Lapatinib; Mice; Mice, Transgenic; Pituitary Neoplasms; Prolactinoma; Protein Kinase Inhibitors; Quinazolines; Translational Research, Biomedical | 2017 |
2 other study(ies) available for gefitinib and Pituitary Neoplasms
| Article | Year |
|---|---|
Clinical and prognostic role of annexin A2 in adamantinomatous craniopharyngioma.
Topics: Adolescent; Adult; Aged; Annexin A2; Antineoplastic Agents; Brain; Cell Movement; Cell Proliferation; Child; Child, Preschool; Cohort Studies; Craniopharyngioma; ErbB Receptors; Female; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Oncogene Protein v-akt; Pituitary Neoplasms; Prognosis; Quinazolines; Signal Transduction; Tumor Cells, Cultured; Young Adult | 2017 |
Rat prolactinoma cell growth regulation by epidermal growth factor receptor ligands.
Topics: Animals; Antineoplastic Agents; Base Sequence; Blotting, Western; Cell Division; Cell Line, Tumor; Cell Proliferation; DNA Primers; ErbB Receptors; Female; Flow Cytometry; Gefitinib; Gene Expression; Immunoprecipitation; Ligands; Mice; Mice, Nude; Pituitary Neoplasms; Polymerase Chain Reaction; Prolactinoma; Quinazolines; Rats | 2008 |